Answers are grounded in this paper and cite their sources.
Background Uterine corpus endometrial carcinoma (UCEC) lacks reliable molecular biomarkers for early detection and classification. While pathway-based prognostic models have been reported, the role of organelle dysfunction, particularly Golgi biology, remains uninvestigated. We aimed to identify Golgi apparatus-related genes (GARGs) of diagnostic value and construct a classification signature for UCEC. Methods Transcriptomic data from TCGA-UCEC (549 tumors; normal controls from TCGA and GTEx) and GEO (GSE17025, 91 tumors) were analyzed. Differentially expressed GARGs were identified, and an integrative machine learning framework was used to build a diagnostic model distinguishing UCEC from normal tissue. Overall survival association and immune infiltration (CIBERSORT) were assessed as exploratory analyses. Results A four-gene GARG signature—CDK1, CCNB2, KIF20A, and PKMYT1—was identified. It distinguished UCEC from normal tissue with an AUC of 0.703 (95% CI 0.646–0.760) in TCGA and 0.927 (95% CI 0.844–1.000) in GSE17025. In an exploratory analysis, a higher signature score was associated with shorter overall survival (log-rank P = 0.027). Immune cell composition differed between UCEC and normal tissue. The four genes were enriched in cell-cycle (G2/M) and proliferation-related pathways; KIF20A showed the largest coefficient, and CDK1 was consistently identified across independent cancer models. Conclusions We identified a GARG-derived classification signature for UCEC, in which CDK1 and KIF20A are prominent members. Associations with survival and immune features are exploratory and should be interpreted cautiously. Because these genes are canonical cell-cycle regulators, whether the signature reflects Golgi-specific biology or generic proliferation requires functional validation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: